Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(23):1996-1998; doi:10.1093/jnci/91.23.1996
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Moulton, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moulton, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 23, 1996-1998, December 1, 1999
© 1999 Oxford University Press

NEWS

Informing Confident Decisions When Weighing Uncertain Risks

Gwen Moulton

At a recent cancer control conference an audience member stood up and quoted the adage that more men will die with prostate cancer than from it. Then she asked the expert panel why men should be screened for prostate cancer at all when doctors do not seem to agree on the most effective screening techniques, the follow-up treatment, or the long-term risk.

Such controversies create perplexing problems in informing patients, medical practitioners, and public health officials about the current scientific consensus, or lack of it, on the effectiveness of screening for various types of cancer — as measured . . . [Full Text of this Article]

Value Conflicts

Randomized Trial


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?